Paradigm Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.
Paradigm Therapeutics has raised $25.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Paradigm Therapeutics's investors include Eshelman Ventures.
Paradigm Therapeutics is headquartered in Mt Pleasant, United States.
Paradigm Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.
Paradigm Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paradigm Therapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/paradigm-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Paradigm Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/paradigm-therapeutics
{{cite web |title=Paradigm Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/paradigm-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated